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Mechanism of the antihypertensive effect of K depletion in the sponta-
neously hypertensive rat. K depletion reverses hypertension in the SHR
(systolic blood pressure: K deplete 122 5 vs. K replete 164 4 mm
Hg, P < 0.001). To determine the role of the renin angiotensin system
in the protective effect of K depletion, we performed studies of vascular
reactivity in intact SHR and of angiotensin II (Ang II) binding to
mesenteric artery particles and vascular smooth muscle cells (VSMC)
in culture from SHR. Pressor sensitivity to Ang II (± converting
enzyme inhibition) but not norepinephrine was reduced in K depleted
SHR. Thus, the decreased vascular reactivity in K depletion was
specific for Ang II rather than a generalized defect. Ang II binding and
receptor number (Bmax) (156 20 vs. 81 5 fmol/mg of protein, P <
0.01) were increased in K depleted mesenteric artery particles, Since K
depletion and increases in Ang II have both been associated with
increased Ang LI binding, Ang II binding was measured after bilateral
nephrectomy. Despite reduction of plasma renin activity, total binding
and Bmax were still increased in nephrectomized K depleted SHR. To
determine the specific effect of K depletion independent of Ang II on
Ang II binding, studies were performed in mesenteric artery VSMC
from SHR grown in culture. VSMC from K replete SHR were grown to
confluency in K replete medium and then were incubated in K depleted
medium for 24 hours. Binding was saturable, time and temperature-
dependent in K replete and K depleted cells. Total binding and Bmax
(139 13 vs. 93 7 fmol/mg protein, P < 0.01) were increased in K
depleted cells. The protective effect of K depletion in SHR is mediated
by a decrease in vascular responsiveness to Ang II. Since Ang II
binding is increased in both K depleted mesenteric arteries and in K
depleted VSMC, the decrease in vascular responsiveness is the result of
a K depletion-induced post-binding defect.
The hemodynamic effects of deficits in K are complex. For
example, perfusion of isolated vessels from K replete animals
with hypokalemic solutions results in an increase in vascular
resistance [1—31. In contrast, total body K depletion results in a
decrease in systemic vascular resistance [4, 5]. The vasodila-
tory effect of total body K depletion extends to some forms of
experimental hypertension, including the SHR. The protective
effect of K depletion in the SHR is mediated by a reduction in
systemic vascular resistance [6]. Since the reduction in sys-
temic vascular resistance is associated with a threefold increase
in plasma renin activity (PRA) [6], the protective effect of K
Received for publication July 23, 1987
and in revised form December 7, 1987
© 1988 by the International Society of Nephrology
18
depletion must be mediated, at least in part, by a reduction in
angiotensin II (Ang II) pressor sensitivity.
The pressor effect of Ang II follows binding of the hormone to
a membrane receptor on vascular smooth muscle and a series of
post-binding biochemical reactions, Studies using membrane
preparations from intact animals show that both K and Ang II
alter Ang II binding [7—li]. Since K depletion activates the
renin-angiotensin axis, changes in Ang II binding in K depletion
could be mediated primarily by K depletion or indirectly by
activation of the renin-angiotensin system. The purpose of our
current study, therefore, was to determine whether decreases in
Ang II pressor sensitivity in K depleted SHR are mediated by
binding or post-binding defects and whether these defects were
caused by K depletion or K depletion-induced increases in Ang
II.
Methods
Male 8-week-old SHR (Charles River Breeding Laboratories,
Wilmington, Massachusetts, USA) were used for study. All rats
were maintained on standard rat chow (Wayne Laboratory,
Wayne, Indiana, USA) for one week after which animals were
placed on the following diets.
1. A severely K-depleted diet (ICN Pharmaceutical, Cleveland,
Ohio, USA) containing potassium, 5 mEq/kg, and supple-
mented with magnesium.
2. Standard rat chow containing potassium, 260 mEq/kg. In
earlier studies we reported that the natural history of hyper-
tension was the same in SHR consuming this diet or a K
replete diet prepared by adding a mixture of potassium salts,
240 mEq/kg, to the severely potassium-depleted, magnesium
supplemented diet [6].
The final composition of these diets has been reported [12].
After two to three weeks of the respective diets, we per-
formed the following studies: Study I was designed to deter-
mine the effect of K depletion on vascular sensitivity in the
SHR. Systolic blood pressure was determined weekly and
plasma K and PRA were determined at the time of sacrifice in
SHR on the K replete and the K depleted diets. In other rats
pressor dose response curves were determined after Ang II or
norepinephrine. To determine the importance of prior receptor
occupancy with endogenous Ang II, the pressor response to
exogenous Ang II was determined after a single dose of
converting enzyme inhibitor (CEI).
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Study II was designed to determine the effect of K depletion
on Ang II binding to vascular smooth muscle particles from the
SHR. Ang II binding studies were performed on mesenteric
artery membrane preparations from K depleted and K replete
SHR.
Study III was designed to determine the effect of K depletion,
in the absence of renal renin, on vascular reactivity and Ang II
binding. Twenty-four hours prior to study, K replete and K
depleted SHR underwent bilateral nephrectomy to remove the
renal source of renin production. Following nephrectomy, food
was withheld but animals were allowed free access to water.
PRA was determined in five animals in each group.
To determine the effects of K depletion in the absence of Ang
II on Ang II binding, Study IV was performed in vascular
smooth muscle cells (VSMC) in culture. Mesenteric artery
VSMC from 8-week-old SHR were grown to confluency in K
replete medium. The medium was then changed to K deficient
(1.8 mrvi K) or K replete (5.2 mis'i K). After 24 hours, Ang II
binding studies were performed.
Systolic blood pressure
Systolic blood pressure was measured by a tail-cuff plethys-
mographic technique (Narco Biosystems, Houston, Texas,
USA) and recorded on a polygraph (Gilson Medical Electronics
Inc., Madison, Wisconsin, USA).
Ang II and norepinephrine pressor response
Animals were anesthetized with pentobarbital, and polyeth-
ylene catheters (PE-50) were placed in the femoral artery and
vein for direct arterial pressure monitoring and drug adminis-
tration, respectively. During surgery (7 to 10 mm), rats were
given volume replacement of 0.5% body weight with 0.9%
NaC1. After surgery, animals were replaced with 1.5 ml NaCl
per hour. Thirty minutes after surgery, pressor response studies
were performed as previously described [13] by administering
an intravenous bolus of Ang!! (Sigma Chemical Co., St. Louis,
Missouri, USA) in doses of 12.5, 25, 50, and 100 ng. In
additional animals norepinephrine (fevarterenol bitartrate, Ster-
ling Drug, New York, USA) in doses of 50, 100, 200, 400 ng was
administered. Mean arterial pressure (MAP) was measured with
a Bell and Howell pressure transducer (type 4-327-!, Bell and
Howell Co., Pasadena, California, USA) and recorded on a
polygraph. After MAP had returned to baseline (2 to 3 mm) a
period of 10 minutes was allowed before the next dose of
pressor agent. In additional studies, the pressor response to
exogenous Ang II was determined after one dose of CE! or
blank. Captopril (SQ 14225, E.R, Squibb and Sons, Princeton,
New York, USA) was given as a 25 mg/kg intravenous bolus.
One hour later the pressor response to Ang I! was determined
using the previously described protocol. The adequacy of
converting enzyme inhibition was ascertained by determining
the pressor response to 50 ng of angiotensin I (Sigma Chemical
Co., St. Louis, Missouri, USA) before the administration of
captopril and 10 minutes after the last dose of Ang I!. All
animals had a decrease in pressor response to Angiotensin I of
at least 90%.
Plasma determinations
Animals were anesthetized with ether and a polyethylene
catheter was placed in the femoral artery. One hour after
recovery from anesthesia, blood was withdrawn rapidly and
placed in chilled tubes for determination of K and PRA. The
blood was immediately centrifuged at 4°C. The plasma was then
decanted and stored at —20°C until it was analyzed.
Plasma K was measured with an IL 343 Flame Photometer
(Instrumentation Laboratories, Inc., Lexington, Massachusetts,
USA). PRA was measured by RIA [14].
Vascular smooth muscle cell culture
The techniques for isolation and culture of mesenteric artery
VSMC are modifications of those described by Ives et al [15]
and Gunther et al [16]. Male SHR weighing 225 to 250 g,
maintained on standard laboratory chow and tap water ad lib,
were sacrificed by cervical dislocation. The superior mesenteric
artery with its major branches were excised, en block, from its
origin at the aorta to the mesenteric border of the intestine, and
placed in ice-cold minimum essential medium with Earle's salts
(MEM) (Gibco Laboratory, Grand Island, New York, USA).
Fat, adventitia, and venous structures were removed by blunt
dissection, and the cleared mesenteric artery arcades (usually 3
per preparation) were transferred into a flask containing 5.0 ml
of Enzyme Dissociation Mixture: MEM, 0.25 mg/mI elastase
(Sigma Type III, 90 U/mg, Sigma Chemical Co.) 0.75 mg/mi
soybean trypsin inhibitor (Sigma, Type iS, Sigma Chemical
Co.), 1.0 mg/mI collagenase (Type!, Worthington Biochemical
Corp., 135 to 180 U/mg, Sigma Chemical Co.) and 2.0 mglml
crystallized bovine albumin. After incubation at 37°C for 120
minutes in a gyratory shaker bath, the tissue suspension was
aspirated with a pasture pipette and passed through a 100 sm
nylon mesh to separate dispersed cells from undigested vessel
wall fragments and debris. The filtered suspension was centri-
fuged in a siliconized conical glass tube (200 g, 10 mm) and the
cell pellet resuspended in 10 to 15 ml of MEM supplemented
with 10% (vol/vol) bovine albumin, 100 U/mI penicillin and 100
g/ml streptomycin.
This dispersed cell suspension was aliquoted into three 25
cm2 tissue culture flasks (6 to 8 x io cells/cm2), which were
incubated at 37°C in a humidified 5% CO2 95% air atmosphere.
After three to five hours the cultures were washed once with
MEM to remove nonadherent cells and debris, and fed with
fresh medium. Medium was routinely exchanged at 48 to 72
hour intervals thereafter.
Cells were propagated in MEM with 10% calf serum and
antibiotics and passaged once a week by harvesting with trypsin
and seeded at a ratio of 1:4 in 25 cm2 flasks. For binding
experiments cells between passage levels 3 and 15 were seeded
into 16mm plastic petri dishes at a density of 0.5 x i05 cells in
1.5 ml of culture medium, fed every other day and used after
five to seven days.
To adjust the K content of the medium, cells were washed
and then fed with MEM modified to contain 1.8 or 5.2 mM K
with 10% calf serum. This medium was prepared by utilizing
K-free MEM with Earle's salts and adding the desired K
content.
Receptor binding studies
—Mesenteric artery particles. Preparation of tissue. Studies
of receptor binding of Ang II were performed using mesenteric
artery smooth muscle particles as previously described [17].
Small intestines with attached mesenteries were removed en
20 Linas et a!: K depletion in the SHR
bloc and placed on a piece of filter paper moistened with 0.25 M
sucrose in a glass petri dish atop ice. The mesenteric arteries
and branches were bluntly dissected away from veins and
bowel by using a rubber policeman and fine forceps. Adherent
fat was removed from the arteries with a loose fitting Potter-
Elvehjem mechanical homogenizer. Pooled tissue from three
rats was then suspended in 20 ml of 0.25 M sucrose, minced with
fine scissors, homogenized for 10 seconds twice (Polytron
model PT lOST, Brinkman Instruments, Inc., Westburgh, New
York, USA), and sedimented at 1000 X g for 10 minutes at 4°C.
The supernatant was centrifuged at 100,000 X g for 35 minutes.
The resulting pellet was resuspended in 1.5 ml Tris-HCI with a
Potter-Elvehjem homogenizer.
Receptor binding. All experiments were performed within
three hours of removal of tissue. Incubations were performed in
50 mM Tris-HC1 (pH = 7.4) with 0.8% bovine serum albumin,
120 mivi NaC1, 5 mri MgCl2 and 45 to 150 g protein. Fifteen to
75 x iO' moles of '251-Ang II (New England Nuclear, Boston,
Massachusetts, USA; sp. act. 1880 Ci!mg) and varying amounts
of unlabelled Ang II (10° to 10—8 Sigma Chemical Co.)
were added to the incubation tubes to perform binding inhibi-
tion studies. Nonspecific binding was determined in the pres-
ence of 0.3 M unlabelled Ang II. Total incubation volume was
300 /LI. Binding studies were performed at 22°C for 60 minutes,
at which time binding was stopped by addition of 4 ml of iced
phosphate buffered saline (PBS) to the incubation tube. Recep-
tor bound Ang II was separated from free Ang II on millipore
filters (HAWP 0.45 m, Millipore Corp., Bedford, Massachu-
setts, USA) and rinsed with 4 ml of PBS. Receptor-bound
radioactivity trapped on filters was counted on a Searle gamma
counter (G.D. Searle and Col, Skokie, Illinois, USA) with 63%
counting efficiency. All studies were performed in triplicate,
and binding was corrected for nonspecific binding (<20% of
total binding). Binding constants were determined by Scatchard
analysis of binding data [181 after fitting data to a line by using
the least squares method [191. Protein concentration of the
receptor suspension was determined by a modification of the
method of Lowry et al 1201.
—Vascular smooth muscle cells in culture. The techniques
for the hormone binding assay were a modification of those
described by Gunther et al [16] and Penit, Faure and Jard [21].
For each experiment, K depleted cells were compared to
normokalemic cells at the same passage. Hormone binding was
assayed using intact cells attached to the plastic petri dishes in
which they were grown. At the beginning of the experiment, the
culture medium was aspirated and cells were washed three
times with ice-cold PBS (pH 7.4). Binding assays were per-
formed in assay buffer (50 mM Tris-HCI [pH 7.4], 100 mrvi NaCI,
5 mM MgCl2) with 0.25% bovine serum albumin and 0.5 mg/mI
bacitracin. Five to 50 X 10—15 moles of 1251-Ang II and varying
amounts of unlabelled Ang 11(10—10 to 10-8 M) were added to
the incubation tubes to perform binding inhibition studies. Total
incubation volume was 300 pi. Binding studies were performed
at 4°C for 120 minutes at which time binding was stopped by
rapid removal of the incubation medium and addition of 1 ml of
ice-cold PBS. Free hormone was removed by washing the intact
attached cells five times with 1 ml of ice-cold PBS. After
aspirating the final PBS wash the cells were resuspended in
PBS and detached by scraping with a rubber policeman. Re-
ceptor-bound radioactivity was then counted. All studies were
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Fig. 1. The effect f K depletion on established hypertension in the
SHR. SHR were placed on a K replete diet (A; N = 15)or a K depleted
diet (X; N = 14). Systolic blood pressure was monitored weekly for two
weeks.
performed in triplicate. Specific binding was defined as total
binding minus binding in the presence of 1 M unlabelled Ang
II. Nonspecific binding was less than 5% of the total binding.
Protein concentration of the cellular suspension was deter-
mined by a minor modification of the method of Lowry [20]
(that is, absorbancy was read at 650 rather than 750 nm). In
some studies the number of cells per well was determined by
hemocytometer. In a given experiment the number of cells per
well never varied by more than 10%.
Measurement of cellular K content. Intracellular K was
determined after washing cells five times with isotonic, ice-cold
0.1 M MgCI2. Intracellular K was then extracted with 0.1 N
HNO3 and quantitated by flame photometry.
Statistics
Results are expressed as the mean SEM. Statistical analyses
were made by the unpaired Student's t-test. A P value of <0.05
was considered statistically significant.
Results
Study I: Effects of K deficiency on pressor sensitivity in the
SHR
At the time of study plasma K was 4.02 0.1 (N = 8) in SHR
on the K replete diet and 2.68 0.1 mEq/liter (N = 10) in SHR
on the K depleted diet (P < 0.001). Figure 1 demonstrates that
K depletion reversed hypertension in the SHR. For example,
after two weeks of dietary K restriction, systolic blood pressure
was 164 4 mm Hg in K replete rats compared to 122 5 mm
Hg (P < 0.001) in K depleted rats. PRA was 1.6 0.3 (N = 8)
in K replete rats and 5.8 0.6 ng Al/mi/hr (N = 8) in K depleted
rats (P < 0.001).
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Figure 2 demonstrates the pressor response to graded doses
of Ang II in K replete and K depleted SHR. The pressor
response to Ang II in K depleted SHR was 50 to 60% of that of
K replete SHR receiving the identical dose of Ang II. To
determine whether receptor occupancy with endogenous Ang II
was the cause of the decreased pressor sensitivity to exogenous
Ang II, K depleted SHR were given a single dose of captopril.
Table 1 demonstrates that after one dose of captopril, MAP was
unchanged. In addition, the pressor response to Ang II re-
mained abnormal. These results suggest that the decreased
pressor response to exogenous Ang II in K depleted SHR is not
the result of receptor occupancy with endogenous hormone.
The pressor response of graded doses of norepinephrine in K
replete and K depleted SHR is shown in Figure 2. The pressor
response of K depleted SHR was comparable to that of K
replete SHR. Since the norepinephrine pressor responses of K
replete and K depleted SHR were comparable, the decrease in
pressor sensitivity in the K depleted SHR was specific for Ang
II and not caused by a generalized defect in vascular reactivity.
Study Ii: Effects of K deficiency on Ang II binding in
mesenteric artery particles
To determine whether the decrease in pressor sensitivity to
Ang II was caused by a decrease in binding of Ang II to its
putative vascular smooth muscle membrane receptor, we per-
formed receptor binding studies on membrane fractions pre-
pared from mesenteric arteries. In K replete and K depleted
SHR, steady-state binding data revealed a single class of
receptors with high binding affinity. Binding was saturable over
a protein concentration of 20 to 200 g membrane protein/300 tl
incubation volume. Time course studies revealed maximal
binding between 30 and 60 minutes.
Figure 3 demonstrates total binding with increasing doses of
Ang II. Ang II binding to K depleted membranes was equal to
or greater than Ang II binding to K replete membranes at each
concentration of Ang II. Scatchard transformation of the bind-
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Table 1. Angiotensin II pressor sensitivity in K deplete SHR after
converting enzyme inhibition
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Fig. 2. Pressor dose response curves to Ang
II and norepinephrine in the SHR. A. Ang II;
K replete (A; N = 6), K depleted (X; N = 6).400 B. Norepinephrine; K replete (X; N = 5), K
depleted (A; N = 6). * P < 0.01 vs. K replete.
K depleted(N = 6) 103 6 3.8 1.8 10.9 2.3 18.1 2.9 26.4 4.1
K depleted + CE!
(N = 5) 107 5 3.4 2.2 12.5 2.6 16.3 2.7 23.9 3.3
P value NS NS NS NS NS
Responses in mm Hg above basal MAP. Numbers in parenthesis are
number of animals.
Abbreviations are: MAP, mean arterial pressure; CE!, converting
enzyme inhibitor.
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Fig. 3. Ang II binding to mesenteric artery membrane fractions from K
replete (A; N = 8) and K depleted (X; N 8) SHR.
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Table 2. Angiotensin II receptor binding constants in mesenteric
arteries of SHR
Group
13max
fmol/mg protein
Kd
n.i
K replete
(N =8)
K depleted(N=8)
P value
81 5
156 20
<0.01
1.7 0.4
1.4 0.2
NS
Abbreviations are: Bmax total number of binding sites; Kd, apparent
equilibrium dissociation constant; N, number of experiments, 3 animals
per experiment.
0 2 4 6 8 10
Table 3. Pressor dose-response curves to angiotensin IL in
nephrectomized K replete and K depleted SHR
Change in MAP (mm Hg)
dose of angiotensin LIBasal
MAP ng
mm Hg 12.5 25 50 100
K replete nephrectomized(N = 5) 142 4 15.8 1,7 24.5 2.5 34.2 2.2 44.3 2.3
K depleted nephrectomized(N = 5) 105 5 4.2 1.8 10.3 1.9 16.6 2.3 24.1 2.8
P value <0.001 <0.001 <0.001 <0.001 <0.001
Responses in mm Hg above baseline. Numbers in parenthesis are
numbers of animals.
ing data (Table 2) revealed an increase in the number of binding
sites (Bmax) in K depleted SHR. The apparent equilibrium
dissociation constant (Kd) was similar in the two groups. Since
binding was increased, these results suggest that the reduction
in Ang II pressor sensitivity in K depletion is not caused by
decreases in Ang II binding to its vascular smooth muscle
receptor.
Study III: Role of increased endogenous Ang lion Ang II
binding in K depleted SHR
Since K depletion is associated with increases in PRA and
since we have shown that moderate increases in PRA are
associated with increases in Ang II binding in renovascular
hypertension [13], we questioned whether the increase in bind-
ing in the K depleted SHR was a direct consequence of K
depletion or was secondary to K depletion-induced increases in
Ang II. To answer this question, we determined the effects of K
depletion on Ang II vascular reactivity and Ang II binding in
SHR which had undergone bilateral nephrectomy to remove the
renal source of renin production. Following nephrectomy PRA
was reduced to less than 1 ng AlJml/hr in both K replete and K
depleted SHR. Table 3 demonstrates that MAP and Ang II
vascular responsiveness were reduced in nephrectomized K
depleted SHR compared to K replete SHR. Figure 4 demon-
strates that Ang II binding to membranes from nephrectomized
K depleted SHR was equal to or greater than Ang II binding to
membranes from nephrectomized K replete SHR at each con-
centration of Ang II. Table 4 indicates that increases in Ang II
binding in nephrectomized K depleted membranes resulted
from increases in the number of binding sites. This data
ANJG II concentration, flM
Fig. 4. Ang II binding to mesenteric artery membrane fractions from K
replete (•; N = 5) and K depleted (; N = 6) SHR which had
undergone bilateral nephrectomy (Nx) 24 hours prior to binding studies.
Table 4. Angiotensin II receptor binding constants in mesenteric
arteries of nephrectomized SHR
Group
Bmax
fmol/mg protein
Kd
nw
K replete nephrectomy(N = 5) 74 10 1.2 0.2
K depleted nephrectomy(N=6) 136±13 1.3±0.3
P value <0.01 NS
Abbreviations are: Bmx, total number of binding sites; Kd, apparent
equilibrium dissociation constant; N, number of experiments, 3 animals
per experiment.
suggested that the decrease in Ang II vascular reactivity and the
increase in Ang II binding in K depleted SHR resulted from K
depletion per se rather than from K depletion-induced increases
in Ang II.
Study IV: Effects of K depletion in VSMC in culture
Since nephrectomy inactivates the renal but not the vascular
renin-angiotensin system and since nephrectomy is associated
with changes in other substances which could alter Ang II
binding, we measured Ang II binding to VSMC in culture which
had been exposed to a K deficient medium for 24 hours.
Intracellular K was decreased by 10% from 1504 56 (N = 5)
in K replete cells to 1327 44 mEq K/mg (N = 5) cell protein
in K deficient cells, P < 0.05. Steady-state binding data
revealed a single class of receptors with high binding affinity.
Binding was saturable in both K replete and K depleted VSMC
over a protein concentration of 50 to 250 p.g protein/300 d
incubation volume. Protein content was similar in both K
replete and K depleted cells. Time course studies revealed
maximal binding between 120 and 150 minutes at 4°C.
Figure 5 demonstrates Ang II binding in K deficient and K
replete cells. Ang II binding to cells incubated in a K deficient
medium was greater than Ang II binding to cells incubated in a
K replete medium at each concentration of Ang II. Scatchard
analysis of the binding data indicated that increases in binding
in cells grown in a K deficient medium resulted from increases
in Bmax (Table 5, Fig. 6). The apparent equilibrium association
2
I
120
80
40
0
Linas et at: K depletion in the SHR 23
Groups
Bmax
fmol/mg protein
Kd
flM
K replete cells 93 7 1.2 0.2
(N =8)
K depleted cells 139 13 1.5 0.2
(N = 10)
P value <.01 NS
constant (Kd) was similar in the two groups. This data confirms
the data obtained from nephrectomized K depleted SHR and
suggests that the increase in Ang II binding in K depletion
results from K depletion per se rather than from increases in
Ang II caused by K depletion.
Discussion
Chronic dietary K depletion reverses both early and estab-
lished hypertension and reduces Ang II pressor sensitivity in
the SHR [6]. Many of the usual factors postulated to cause
hypertension in the SHR [22, 23] are unaffected or made worse
by K depletion. In this regard, plasma catecholamines are
unchanged [12] while cardiac index, plasma volume and renin
are increased [6, 12], and urinary Na [24] and chloride excretion
[25] are decreased in K depletion. Since a reduction in All
pressor sensitivity could be a mechanism by which K depletion
ameliorates hypertension in the SHR, we focused on the
mechanism for decreased Ang II pressor sensitivity in K
depleted SHR. The possibilities we investigated included: 1) a
generalized decrease in vascular reactivity; 2) receptor occu-
pancy with endogenous hormone; and 3) changes in binding of
Ang II to its vascular receptor.
Since K depleted rats do not grow at the same rate as K
replete rats [6, 12], it was possible that the decrease in Ang II
pressor sensitivity was caused by a generalized decrease in
vascular reactivity mediated by malnutrition. However, norepi-
nephnne pressor sensitivity was preserved in K depleted SHR.
In addition, Ang II but not norepinephrine pressor sensitivity is
ANG II bound, fmol/mg protein
Fig. 6. Scatchard analysis of Ang II binding to cultured vascular
smooth muscle cells. Cells were incubated in a K replete medium or a
K depleted medium for 24 hours prior to binding studies. Values are the
means of triplicate determinations from a single experiment.
reduced in K depleted aortic strips [26]. This data indicates,
therefore, that the decreased pressor effect of Ang II in K
depleted SHR is selective for Ang II rather than part of a
generalized decrease in vascular reactivity.
To evaluate receptor occupancy as the cause of vascular
hyporesponsiveness in K depletion, we administered convert-
ing enzyme inhibitor. Ang II pressor insensitivity persisted after
converting enzyme inhibitor. In addition, there was no decrease
in basal MAP after converting enzyme inhibitor. The lack of
hypotensive effect in K depleted SHR differs from the 20%
reduction in MAP reported in K replete SHR [27, 28]. These
results suggest that there is pressor resistance to both endoge-
nous and exogenous Ang II in K depleted SHR and that
vascular hyporesponsiveness is not caused by receptor occu-
pancy. Moreover, the results suggest that K depletion exerts its
protective effect in the SHR by offsetting the Ang II component
of hypertension.
Ang Il-induced vascular contraction follows binding of the
hormone to a receptor on vascular smooth muscle. To deter-
mine if decreases in binding could account for Ang II vascular
hyporesponsiveness in K depletion, we measured Ang II bind-
ing to mesenteric artery segments of K replete and K depleted
SHR. Total Ang II binding and Bmaxwere increased in vascular
segments of K depleted SHR (Fig. 3). In earlier studies we
showed that both K depletion and small increases in Ang II
were associated with increases in Ang II binding to mesenteric
vasculature [13, 17]. Since Ang II levels are increased in K
depletion [29], to distinguish whether increases in binding and
Bmax were caused by K depletion itself or to K depletion-
induced increases in Ang II, we measured binding under two
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Fig. 5. Ang II binding to cultured rat mesenteric artery smooth muscle
cells. Cells were incubated in a K replete medium (A; N = 8) or a K
depleted medium (X; N = 10) for 24 hours prior to binding studies.
Table 5. Angiotensin II receptor binding constants in mesenteric
artery, vascular smooth muscle cells grown in culture
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Abbreviations are: Bmax, total number of binding sites; Kd, apparent
equilibrium dissociation constant; N, number of experiments.
24 Linas et a!: K depletion in the SHR
conditions in which K depletion could be dissociated from Ang
II: in arteries from nephrectomized K depleted SHR and in
VSMC cultured in a defined K depleted medium. In both
experiments, K depletion was associated with increases in total
Ang II binding and Bmax. The results demonstrate, therefore,
that increases in Ang II binding and Bmax in K depletion are
caused by K depletion rather than by K depletion-induced
increases in Ang II.
Increases in Bmax in K depleted VSMC could reflect increases
in the total pooi of Ang II receptors or redistribution of
receptors from the cytosol to the cell surface. In this regard, K
depletion arrests the formation of coated pits and prevents
endocytosis of receptor-bound low density lipoprotein and
epidermal growth factor in fibroblasts [30]. Since Bmax was
increased when binding was performed at 4°C, a temperature
which prevents internalization of receptor bound ligand [31],
the data suggests that K depletion in VSMC results in increases
in the total pool of Ang II receptors. However, it is also possible
that receptor redistribution occurred prior to binding studies
during the 24 hours of exposure to the K deficient medium.
Since Ang II is a hydrophilic ligand, binding data at 4°C reflects
cell surface receptors rather than the total receptor pool.
Further studies utilizing ligands with direct access to cytosolic
receptors or a soluble receptor assay system will be required to
determine if K depletion results in an increase in the total
receptor pool or receptor redistribution.
Since we found Ang II binding to be increased in both K
depleted mesenteric arteries and vascular smooth muscle cells
grown in a K deficient medium, the decreased pressor sensitiv-
ity in the K depleted SHR is the result of a K depletion-induced
post-binding biochemical defect. The post-receptor biochemical
defect in K depletion is not known. Both norepinephrine and
Ang IT-induced vascular contraction are mediated by phos-
phatidyl inositol hydrolysis, mobilization of intracellular cal-
cium and phosphorylation of myosin [32—34]. Since Ang II, but
not norepinephrine, pressor sensitivity is decreased in K de-
pleted SHR, the results of our study suggest that the post-
binding defect in K depletion occurs prior to activation of
phospholipase C, for example at the interaction of the hormone-
receptor complex with guanine nucleotide regulatory proteins.
K depletion is also associated with amelioration of hyperten-
sion and reduction in Ang II pressor sensitivity in renovascular
hypertension [12]. The mechanism of protection in renovascu-
lar hypertension is different, however, than in the SHR. In
renovascular hypertension, K depletion is associated with both
decreases in Ang II binding as well as a post-binding defect [35],
whereas in the SHR, K depletion is associated with increases in
binding and a post-binding defect. The results of these two
studies underscore the complexity of control of Ang II binding
in vivo and demonstrate the importance of both K and Ang lion
Ang II binding, In the absence of Ang II (for example, as occurs
in VSMC in culture or in nephrectomized K depleted SHR) K
depletion causes increases in binding. In the absence of K
depletion, the regulatory effects of Ang II are dose-dependent.
Large increases in Ang II decrease binding [9, 10]. Small
increases in Ang II do not decrease binding and may increase
binding [13]. In the setting of K depletion, the effects of Ang II
are also dose-related. Whereas large increases in Ang II de-
crease binding [35}, small increases in Ang II, as in K depleted
SHR, do not cause down-regulation (Figs. 3, 4).
In summary, we have shown that the decrease in Ang II
pressor sensitivity in the K depleted SHR is: 1) specific for Ang
II; 2) not mediated by receptor occupancy with endogenous
hormones; and 3) associated with increases in binding and Bmax
in mesenteric artery particles from intact and nephrectomized
animals as well as in VSMC grown in a K deficient medium.
Since Ang II binding is increased in both K depleted mesenteric
arteries and in VSMC grown in a K deficient medium, the
decreased Ang II pressor sensitivity in the K depleted SHR is
the result of a K depletion-induced post-binding biochemical
defect.
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